Pila Pharma AB (publ) (STO:PILA)

Pila Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	60	87	102	38	50	109
Market Cap Growth	-43.17%	-14.78%	167.21%	-23.60%	-54.48%	-
Enterprise Value	44	86	99	38	45	77
Last Close Price	1.32	2.06	3.75	1.60	3.10	6.64
PS Ratio	53.34	76.92	128.78	26.02	26.50	152.22
PB Ratio	4.07	5.86	19.33	5.72	5.23	3.61
P/TBV Ratio	4.07	5.86	24.31	8.45	7.91	4.05
EV/Sales Ratio	39.24	75.96	125.56	26.26	23.77	106.59
Net Debt / Equity Ratio	-1.07	-1.07	-0.93	-0.89	-0.76	-0.93
Net Debt / EBITDA Ratio	2.33	2.33	0.70	1.12	0.82	3.05
Asset Turnover	0.10	0.10	0.11	0.15	0.09	0.04
Quick Ratio	11.19	11.19	5.16	3.47	5.49	18.72
Current Ratio	11.26	11.26	5.21	3.48	5.59	18.81
Return on Equity (ROE)	-168.25%	-168.25%	-188.57%	-122.66%	-134.47%	-102.07%
Return on Assets (ROA)	-43.97%	-43.97%	-69.05%	-41.32%	-26.03%	-31.14%
Return on Capital Employed (ROCE)	-53.40%	-53.40%	-154.10%	-96.00%	-93.30%	-30.60%
Earnings Yield	-28.05%	-19.45%	-11.05%	-26.08%	-53.74%	-15.72%
Buyback Yield / Dilution	-35.92%	-35.92%	-20.66%	-22.29%	-31.86%	-30.89%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.